Clinical Trial Results

Showing: All studies [change]
Condition: Kidney Disease Location: New Jersey 12 trials found
New Search
Filter
Trial Phase
Study Type
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
PHASE2, PHASE3INTERVENTIONAL Alabaster, Alabama +4 more
RECRUITING
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
PHASE2, PHASE3INTERVENTIONAL Decatur, Alabama +4 more
RECRUITING
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
PHASE3INTERVENTIONAL Fairhope, Alabama +4 more
RECRUITING
A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.
PHASE2INTERVENTIONAL Surprise, Arizona +4 more
RECRUITING
AK+ Guard™ Pilot Study in Chronic Kidney Disease: Outpatient Diagnostic Accuracy and Remote Monitoring
N/AOBSERVATIONAL Eatontown, New Jersey
RECRUITING
A Study of Luspatercept in People With Anemia
PHASE2INTERVENTIONAL Basking Ridge, New Jersey +4 more
RECRUITING
Rutgers University Study of the Genetics of Kidney Disease
N/AOBSERVATIONAL Piscataway, New Jersey
RECRUITING
Pivotal Study of the Velocity™ pAVF System
NAINTERVENTIONAL Dothan, Alabama +4 more
RECRUITING
SPYRAL GEMINI Pilot Study
NAINTERVENTIONAL Stanford, California +4 more
RECRUITING
Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
N/AOBSERVATIONAL Brooklyn, New York
RECRUITING
Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
PHASE2INTERVENTIONAL Alabaster, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type